Turner Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Turner Investments’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-15,400	Closed	-$709K	–	292
2016 Q3	$709K	Buy	+15,400	New	+$803K	0.23%	128
2016 Q2	–	Sell	-2,850	Closed	-$153K	–	237
2016 Q1	$153K	Sell	2,850 -1,440	-34%	-$84.5K	0.04%	193
2015 Q4	$282K	Buy	4,290 +1,340	+45%	+$82.8K	0.06%	195
2015 Q3	$167K	Buy	+2,950	New	+$191K	0.03%	221
2015 Q2	–	Sell	-7,710	Closed	-$480K	–	375
2015 Q1	$480K	Sell	7,710 -9,490	-55%	-$552K	0.09%	230
2014 Q4	$989K	Sell	17,200 -1,420	-8%	-$79.1K	0.12%	271
2014 Q3	$1M	Sell	18,620 -5,520	-23%	-$292K	0.06%	353
2014 Q2	$1.26M	Sell	24,140 -89,540	-79%	-$4.58M	0.06%	358
2014 Q1	$6.01M	Buy	+113,680	New	+$5.25M	0.16%	186

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Turner Investments's TEVA Position: Q4 2016 in Review

Turner Investments sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 15,400 shares — an estimated $709K sold.

Turner Investments first reported a position in TEVA in Q1 2014 and held it in 9 quarters. The position peaked at $6.01M in Q1 2014. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Turner Investments reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Turner Investments sold 15,400 Teva Pharmaceuticals shares in Q4 2016, an estimated $709K.
Turner Investments first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 9 quarters.
Turner Investments's Teva Pharmaceuticals position peaked at $6.01M in Q1 2014.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Turner Investments's 13F filing for Q4 2016, filed 8 Feb 2017.